Neill M A, Tarr P I, Clausen C R, Christie D L, Hickman R O
Pediatrics. 1987 Jul;80(1):37-40.
During a 12-month period, 14 patients with the hemolytic uremic syndrome were identified in a prospective study of enteric pathogens associated with this disorder. Of the 12 patients with a diarrheal illness preceding the onset of hemolytic uremic syndrome, fecal Escherichia coli O157:H7 was detected in seven (58%), all of whom had bloody diarrhea. Half of the siblings of these patients had concurrent nonbloody diarrhea. No source for infection with this organism was identified. Enteric infection with E coli O157:H7 occurs in the majority of cases of hemolytic uremic syndrome following diarrheal illness in the Pacific Northwest and may represent a previously overlooked cause of hemolytic uremic syndrome in other locales. Evaluation of all cases of hemolytic uremic syndrome for enteric pathogens should routinely include cultures for E coli O157:H7 until results of additional studies clarify the distribution of agents associated with hemolytic uremic syndrome in different geographic regions. These findings may provide new opportunities for the design of therapeutic and preventive strategies in this disorder.
在一项为期12个月的前瞻性研究中,对与溶血尿毒综合征相关的肠道病原体进行研究,共识别出14例溶血尿毒综合征患者。在溶血尿毒综合征发病前出现腹泻疾病的12例患者中,7例(58%)检测到粪便中存在大肠杆菌O157:H7,所有这些患者均有血性腹泻。这些患者的一半兄弟姐妹同时患有非血性腹泻。未发现该病原体的感染源。在太平洋西北地区,腹泻疾病后发生的大多数溶血尿毒综合征病例都存在大肠杆菌O157:H7肠道感染,这可能是其他地区溶血尿毒综合征以前被忽视的病因。对所有溶血尿毒综合征病例进行肠道病原体评估时,常规应包括对大肠杆菌O157:H7的培养,直到更多研究结果明确不同地理区域与溶血尿毒综合征相关病原体的分布情况。这些发现可能为该疾病的治疗和预防策略设计提供新的机会。